BIOCON / NSE / Biotechnology & Drugs
Biocon
1Y Price Trend
Key Information
Recommendations
RatingHold
Target High440.3
Target Low327.75
Target Mean2.75
Target Median18.75
Risk Metrics
Overall RiskModerate risk
Board Risk24.02
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Biocon promoter group declares no encumbrance on shares in FY26 scanx.trade
Biocon Invests Rs 5.47 Crore in Solar Power SPV to Advance Renewable Energy Goals Medical Dialogues
Stock of the day : Biocon Ltd by Target Rs. 440 - Religare Broking Ltd Investment Guru
Accessing capital still difficult for women entrepreneurs today: Biocon founder Kiran Mazumdar-Shaw The Times of India
Biocon founder Kiran Mazumdar-Shaw says India needs patient capital for Biotech BusinessLine
Biocon invests INR 5.48 crore in Karnataka solar SPV Solarbytes
Biocon acquires stake in AMPIN solar project SPV Power Peak Digest
Biocon to Buy 37.8% Stake in Renewable Energy Firm Ampin C&I Power Twelve marketscreener.com
© SharekeyX | Rusaka Technologies 2024-2026

